Interactive Health, Inc. (IHI) entered into a non-binding letter of intent to acquire High Mountain 2 Capital Corporation (TSXV:HMCC.P) (HM2) in a reverse merger transaction on September 27, 2022. Prior to closing, IHI will form the resulting issuer called "Interactive Health International Inc." ("New IHI"). Pursuant to the proposed Transaction, each issued and outstanding common share of IHI will be exchanged into one (1) common share of New IHI on a one-for-one basis after giving effect to the consolidation so that all of the currently issued and outstanding IHI Shares will be exchanged for approximately 44,488,900 New IHI Shares. In connection with the transaction, the common shares in the capital of HM2 currently issued and outstanding, will be consolidated on a one (1) for 1.75 basis immediately prior to the closing of the transaction, and will be exchanged into New IHI Shares post the consolidation. The transaction is subject to approval by the boards of directors of HM2 and IHI; satisfactory completion of due diligence; completion of private placement financing; execution of the formal agreement; exchange acceptance and receipt of requisite regulatory approvals, and if applicable pursuant to Exchange requirements, majority of the minority shareholder approval. The LOI will expires on November 30, 2022 if the formal agreement has not been executed. As of November 30, 2022, HM2 and IHI entered into an agreement to extend the deadline for entering into a formal agreement for the transaction from November 30, 2022, to February 15, 2023.

Interactive Health, Inc. (IHI) cancelled the acquisition of High Mountain 2 Capital Corporation (TSXV:HMCC.P) (HM2) in a reverse merger transaction on April 26, 2023.The LOI was terminated after significant efforts to achieve the intended outcome as outlined in the LOI did not come to fruition.